13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 35 holding rows worth $1,638,431,000.
- Accession
- 0001085146-20-000730
- Filer
- CIK 1544773
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 35 entries on the cover page, a total value of $1,638,431,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,638,431,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 6,625,671 | $134,236,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 6,715,965 | $134,051,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 6,127,434 | $117,463,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 4,306,575 | $105,942,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 919,263 | $80,969,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 1,901,667 | $75,211,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 269,000 | $75,062,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 15,642,064 | $70,859,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,975,000 | $67,762,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 929,036 | $66,575,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 604,604 | $63,217,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 579,666 | $53,608,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 2,986,386 | $53,426,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 356,145 | $45,957,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 2,121,976 | $45,771,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 3,195,796 | $45,029,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,509,327 | $41,778,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,363,724 | $39,238,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,878,395 | $38,432,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 2,314,421 | $32,865,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 550,956 | $32,842,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 3,426,365 | $29,398,000 | thousands by filing date | |
| LIMINAL BIOSCIENCES INC | 53272L103 | COM | 3,287,311 | $27,548,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 1,556,137 | $27,077,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 4,772,190 | $27,058,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 155,800 | $26,673,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 5,166,961 | $20,668,000 | thousands by filing date | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 425,800 | $14,975,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 2,888,888 | $11,989,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 203,788 | $11,286,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 155,000 | $7,177,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 507,739 | $4,945,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 71,300 | $4,441,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 135,000 | $4,134,000 | thousands by filing date | |
| MORPHOSYS AG | 617760202 | ADR | 21,561 | $769,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-20-000730 | this filing | 2020-02-14 | acceptance time not in the bulk data set |